-+ 0.00%
-+ 0.00%
-+ 0.00%

MSD: As we approach peak revenue for some approved indications, Keytruda's growth is expected to slow.

Zhitongcaijing·10/29/2026 11:49:15
Listen to the news
MSD: As we approach peak revenue for some approved indications, Keytruda's growth is expected to slow.